Respiratory, Pulmonology & Allergy
Engineered respiratory formulations providing targeted relief across wet productive cough, dry tickling allergy cough, bronchial asthma, and chronic allergic rhinitis.
Clinical Overview & Pathophysiology
In this therapeutic area, Icon Drugs formulates high-stability compounds meeting pharmacopeial limits for content uniformity, dissolution rates, and organic impurities. Our manufacturing adheres to verified batch repeatability so prescribing clinicians can depend upon predictable bioavailability.
For complete bioequivalence dossiers, stability monographs, or hospital tender supply parameters in Respiratory, Pulmonology & Allergy, please contact our Medical Affairs or Business Enquiry team.
Indications & Conditions5 Addressed
- Productive Wet Cough
- Dry Allergic Cough
- Bronchial Asthma
- COPD Exacerbations
- Allergic Rhinitis
Formulations in Respiratory, Pulmonology & Allergy
Active pharmaceutical formulations manufactured under WHO-GMP compliance
Recoff Syrup
“A Novel & Trusted Bronchodilator — Cough Off with Recoff”
Ambroxol HCl 15 mg + Guaiphenesin 50 mg + Terbutaline 1.5 mg with Menthol
Recoff-DX Syrup
“Safe & Reliable Anti-Cough Solution — An Ideal Anti-Cough Therapy”
Dextromethorphan HBr 10 mg + Phenylephrine HCl 5 mg + Chlorpheniramine Maleate 2 mg
Allerkast Tablets
“Freedom to Breathe in Fresh Air — Freedom from Allergy”
Montelukast Sodium 10 mg + Levocetirizine HCl 5 mg